Computer simulation of a breast cancer metastasis model

被引:72
|
作者
Retsky, MW
Demicheli, R
Swartzendruber, DE
Bame, PD
Wardwell, RH
Bonadonna, G
Speer, JF
Valagussa, P
机构
[1] UNIV COLORADO, COLORADO SPRINGS, CO 80933 USA
[2] ONCOMETR INC, COLORADO SPRINGS, CO 80907 USA
[3] MILAN NATL CANC INST, I-20133 MILAN, ITALY
[4] SENIOR HLTH CARE SOLUT, COLORADO SPRINGS, CO 80909 USA
关键词
breast cancer model; computer simulation; metastatic development; tumor growth;
D O I
10.1023/A:1005849301420
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent analysis of relapse data from 1173 untreated early stage breast cancer patients with 16-20 year followup shows that the frequency of relapse has a double peaked distribution. There is a sharp peak at 18 months, a nadir at 50 months and a broad peak at 60 months. Patients with larger tumors more frequently relapse in the first peak while those with smaller tumors relapse equally in both peaks. No existing theory of tumor growth predicts this effect. To help understand this phenomenon, a model of metastatic growth has been proposed consisting of three distinct phases: a single cell, an avascular growth, and a vascularized lesion. Computer simulation of this model shows that the second relapse peak can be explained by a steady stochastic progression from one phase to the next phase. However, to account for the first relapse peak, a sudden perturbation of that development at the time of surgery is necessary. Model simulations predict that patients who relapse in the second peak would have micrometastases in states of relatively low chemosensitivity when adjuvant therapy is normally administered. The simulation predicts that 15% of T1, 39% of T2, and 51% of T3 staged patients benefit from adjuvant chemotherapy, partially offsetting the advantage of early detection. This suggests that early detection and adjuvant chemotherapy may not be symbiotic strategies. New therapies are needed to benefit patients who would relapse in the second peak.
引用
收藏
页码:193 / 202
页数:10
相关论文
共 50 条
  • [31] Fluoxetine modulates breast cancer metastasis to the brain in a murine model
    Yuriy Shapovalov
    Martha Zettel
    Sara C Spielman
    Stacy A Amico-Ruvio
    Emily A Kelly
    Grayson O Sipe
    Ian M Dickerson
    Ania K Majewska
    Edward B Brown
    BMC Cancer, 14
  • [32] A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis
    Doornebal, Chris W.
    Klarenbeek, Sjoerd
    Braumuller, Tanya M.
    Klijn, Christiaan N.
    Ciampricotti, Metamia
    Hau, Cheei-Sing
    Hollmann, Markus W.
    Jonkers, Jos
    de Visser, Karin E.
    CANCER RESEARCH, 2013, 73 (01) : 353 - 363
  • [33] A New Mouse Model for the Study of Human Breast Cancer Metastasis
    Iorns, Elizabeth
    Drews-Elger, Katherine
    Ward, Toby M.
    Dean, Sonja
    Clarke, Jennifer
    Berry, Deborah
    El Ashry, Dorraya
    Lippman, Marc
    PLOS ONE, 2012, 7 (10):
  • [34] Effects of exercise training on breast cancer metastasis in a rat model
    Alvarado, Antonieta
    da Costa, Rui M. Gil
    Faustino-Rocha, Ana I.
    Ferreira, Rita
    Lopes, Carlos
    Oliveira, Paula A.
    Colaco, Bruno
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2017, 98 (01) : 40 - 46
  • [35] Prediction of nodal metastasis and prognosis in breast cancer: A neural model
    Naguib, RNG
    Adams, AE
    Horne, CHW
    Angus, B
    Smith, AF
    Sherbet, GV
    Lennard, TWJ
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2735 - 2741
  • [36] Fluoxetine modulates breast cancer metastasis to the brain in a murine model
    Shapovalov, Yuriy
    Zettel, Martha
    Spielman, Sara C.
    Amico-Ruvio, Stacy A.
    Kelly, Emily A.
    Sipe, Grayson O.
    Dickerson, Ian M.
    Majewska, Ania K.
    Brown, Edward B.
    BMC CANCER, 2014, 14
  • [37] Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer
    Simon R. V. Knott
    Elvin Wagenblast
    Showkhin Khan
    Sun Y. Kim
    Mar Soto
    Michel Wagner
    Marc-Olivier Turgeon
    Lisa Fish
    Nicolas Erard
    Annika L. Gable
    Ashley R. Maceli
    Steffen Dickopf
    Evangelia K. Papachristou
    Clive S. D’Santos
    Lisa A. Carey
    John E. Wilkinson
    J. Chuck Harrell
    Charles M. Perou
    Hani Goodarzi
    George Poulogiannis
    Gregory J. Hannon
    Nature, 2018, 556 : 135 - 135
  • [38] Effect of voluntary running on metastasis in a mouse model of breast cancer
    Mijwel, Sara
    Rundqvist, Helene
    Lindholm, Carolin
    Strell, Carina
    Roswall, Pernilla
    Pietras, Kristian
    Johnson, Randall S.
    Ostman, Arne
    CANCER RESEARCH, 2016, 76
  • [39] Naringenin reduces lung metastasis in a breast cancer resection model
    Lei Qin
    Lingtao Jin
    Linlin Lu
    Xiaoyan Lu
    Chunling Zhang
    Fayun Zhang
    Wei Liang
    Protein & Cell, 2011, 2 (06) : 507 - 517
  • [40] In vivo model of dormancy in ER breast cancer to bone metastasis
    Gawrzak, S.
    Guiu, M.
    Urosevic, J.
    Fernandez, E.
    Pavlovic, M.
    Gomis, R. R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S82 - S82